AGP Executive Report
Last update: 8 hours agoAI Infrastructure Push: China plans a 2 trillion yuan ($295B) nationwide AI data-center network over five years, relying on domestic chips and state-backed operators to reduce dependence on US suppliers. Brain-Tech Breakthrough: China approved the world’s first commercial brain-computer chip (NEO) for spinal cord injury and paralysis, as Neuralink still awaits FDA clearance. Biotech & Regulation: China’s NMPA approved Akeso’s gumokimab for moderate-to-severe plaque psoriasis, with an additional ankylosing spondylitis review accepted. Digital Cancer Care: A Hong Kong trial found the SUPPORT+ smartphone app plus nurse follow-up helped advanced cancer patients maintain quality of life and reduce unplanned hospitalizations. Heart Health Gap: Global Heart Hub reports women often delay seeking care and face recognition gaps for cardiovascular disease. Public Health & Safety: Hong Kong’s CHP is investigating severe pediatric COVID-19 cases and urges vaccination for high-risk children. Water Access in Practice: China-aid borehole projects in Zimbabwe reached 300 villages, improving access to clean water and cutting waterborne disease risk. China-US Tensions in Health Tech: WuXi AppTec sued the US Defense Department over its blacklist designation, arguing the move is unsupported.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
